Delivery Order SPE2DB20D2104-SPE2DB23FS01Q
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vascepa 1 GM Capsule 120S. The contract, valued at $27,009.35, is a delivery order under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc., which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as a primary vehicle for Cencora, Inc. to provide a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,386.95, is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, with a completion date of July 1, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $7,525.73, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 15, 2023, with a completion date of February 16, 2023. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. The award is not designated as a...
- This federal contract award is for the delivery of VASCEPA 1 GM CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distribution company that serves as a key supplier to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract has a ceiling...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,619.58 firm fixed-price delivery order is for the supply of Vascepa 1 GM capsules. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award, valued at $2,031.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of VASCEPA 1 GM CAPSULE 120S. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by AmerisourceBergen's parent company, Cencora, Inc. This IDC with the DLA Troop Support Medical serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,933.49 firm fixed price delivery order is for the supply of VASCEPA 1 GM capsules. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VASCEPA 1 GM CAPSULE 120S. The $1,519.81 firm fixed-price delivery order was awarded on December 3, 2021, with a completion date of December 6, 2021. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VASCEPA 1 GM capsules. The contract has a ceiling value of $2,428.08 and a period of performance through November 17, 2023. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VASCEPA 1 GM capsules. The $9,151.78 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of May 9, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS01QDelivery Order
This federal contract award is for the delivery of Vascepa 1 GM capsules to the Defense Logistics Agency (DLA) for a total ceiling value of $13,399.15. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 31, 2023, with a completion date of February 1, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 1/31/23 |